GTS Securities’s Turnstone Biologics TSBX Stock Holding History

GTS Securities’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45,163	Closed	-$16.2K	–	1709
2025 Q2	$16.2K	Buy	+45,163	New	+$15.8K	﹤0.01%	1184

GTS Securities's TSBX Position: Q3 2025 in Review

GTS Securities sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 45,163 shares — an estimated $16.2K sold.

GTS Securities first reported a position in TSBX in Q2 2025 and held it in 1 quarter. The position peaked at $16.2K in Q2 2025. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

GTS Securities reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
GTS Securities sold 45,163 Turnstone Biologics shares in Q3 2025, an estimated $16.2K.
GTS Securities first reported a position in Turnstone Biologics in Q2 2025 and held it in 1 quarter.
GTS Securities's Turnstone Biologics position peaked at $16.2K in Q2 2025.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.